BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK. Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far. World J Hepatol 2020; 12(12): 1182-1197 [PMID: 33442447 DOI: 10.4254/wjh.v12.i12.1182] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Nadeem A, Suresh K, Awais H, Waseem S. Epstein-Barr Virus Coinfection in COVID-19. J Investig Med High Impact Case Rep 2021;9:23247096211040626. [PMID: 34428954 DOI: 10.1177/23247096211040626] [Reference Citation Analysis]
2 Assa A, Benninga MA, Borrelli O, Broekaert I, de Carpi JM, Saccomani MD, Dolinsek J, Mas E, Miele E, Thomson M, Tzivinikos C; Gastrointestinal Committee of ESPGHAN. Gastrointestinal Perspective of Coronavirus Disease 2019 in Children-An Updated Review. J Pediatr Gastroenterol Nutr 2021;73:299-305. [PMID: 34117195 DOI: 10.1097/MPG.0000000000003204] [Reference Citation Analysis]
3 Peiter GC, de Souza CBT, de Oliveira LM, Pagliarin LG, dos Anjos VNF, da Silva FAF, de Melo FF, Teixeira KN. COVID-19 liver and gastroenterology findings: An in silico analysis of SARS-CoV-2 interactions with liver molecules. World J Hepatol 2022; 14(6): 1131-1141 [DOI: 10.4254/wjh.v14.i6.1131] [Reference Citation Analysis]
4 Antoon JW, Grijalva CG, Thurm C, Richardson T, Spaulding AB, Teufel RJ 2nd, Reyes MA, Shah SS, Burns JE, Kenyon CC, Hersh AL, Williams DJ. Factors Associated With COVID-19 Disease Severity in US Children and Adolescents. J Hosp Med 2021;16:603-10. [PMID: 34613896 DOI: 10.12788/jhm.3689] [Reference Citation Analysis]
5 Thiebaud PC, Hermand C, Sobotka J, Raynal PA. Acute icteric hepatitis as the first isolated symptom of COVID-19. BMJ Case Rep 2021;14:e242853. [PMID: 34088694 DOI: 10.1136/bcr-2021-242853] [Reference Citation Analysis]
6 Abdelrahman MM, Abdel-Baset AA, Younis MA, Mahmoud MG, Shafik NS. Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study. Clin Exp Hepatol 2021;7:297-304. [PMID: 34712832 DOI: 10.5114/ceh.2021.109225] [Reference Citation Analysis]
7 Woo SM, Davis WD, Aggarwal S, Clinton JW, Kiparizoska S, Lewis JH. Herbal and dietary supplement induced liver injury: Highlights from the recent literature. World J Hepatol 2021; 13(9): 1019-1041 [PMID: 34630872 DOI: 10.4254/wjh.v13.i9.1019] [Reference Citation Analysis]
8 Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375 [PMID: 34876795 DOI: 10.3748/wjg.v27.i42.7362] [Reference Citation Analysis]
9 Taylor DR, Buchanan D, Al-Hasani W, Kearney J, Mazaheri T, Ranasinghe RNK, Dimitriadis GK, Vincent RP. Biochemical abnormalities in COVID-19: a comparison of white versus ethnic minority populations in the UK. J Clin Pathol 2021:jclinpath-2021-207446. [PMID: 34011620 DOI: 10.1136/jclinpath-2021-207446] [Reference Citation Analysis]
10 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021; 9(27): 7998-8007 [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
11 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021;9:7998-8007. [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
12 Anirvan P, Singh SP, Giammarino A, Satapathy SK. Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence. World J Hepatol 2021; 13(8): 916-925 [PMID: 34552698 DOI: 10.4254/wjh.v13.i8.916] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]